Advertisement
Advertisement

CLDI

CLDI logo

Calidi Biotherapeutics, Inc.

1.00
USD
Sponsored
-0.05
-4.76%
Jan 30, 15:57 UTC -5
Closed
exchange

After-Market

1.02

+0.02
+2.50%

CLDI Earnings Reports

Positive Surprise Ratio

CLDI beat 5 of 9 last estimates.

56%

Next Report

Date of Next Report
--
Estimate for Q-- -- (Revenue/ EPS)
--
/
--
Implied change from Q3 25 (Revenue/ EPS)
--
/
--
Implied change from Q-- -- (Revenue/ EPS)
--
/
--

Calidi Biotherapeutics, Inc. earnings per share and revenue

On Nov 13, 2025, CLDI reported earnings of -2.21 USD per share (EPS) for Q3 25, missing the estimate of -1.71 USD, resulting in a -28.97% surprise. Revenue reached --, compared to an expected --, with a --% difference. The market reacted with a +0.66% price change (close before vs. close after earnings).
Looking ahead to -- --, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Regeneron Pharmaceuticals Inc
Report Date
Jan 30, 2026 For Q4 25
Estimate
$10.84
Actual
$11.44
Surprise
+5.52%
logo
Nurix Therapeutics, Inc. Common stock
Report Date
Jan 28, 2026 For Q4 25
Estimate
-$0.88
Actual
-$0.82
Surprise
+7.66%
FAQ
For Q3 2025, Calidi Biotherapeutics, Inc. reported EPS of -$2.21, missing estimates by -28.97%, and revenue of --, -- -- expectations.
The stock price moved up 0.66%, changed from $1.51 before the earnings release to $1.52 the day after.
The next earning report is scheduled for --.
Based on -- analysts, Calidi Biotherapeutics, Inc. is expected to report EPS of -- and revenue of -- for Q-- --.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement